Log in or Sign up for Free to view tailored content for your specialty!
Rheumatology News
‘Era of AI is here,’ but not yet reducing physician burnout
Rapidly advancing technology in artificial intelligence and other spaces has yet to deliver on “the promise” of minimizing physician workload and burnout, according to a speaker at the Ending Clinician Burnout Global Community summit.
Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of August 19, 2024
In this edition, drug discounts through Medicare price negotiations, opioid use has fallen 15% annually since 2014 and more.
Log in or Sign up for Free to view tailored content for your specialty!
Gout cases estimated to increase more than 70% worldwide by 2050
The total number of patients with gout across the world is estimated to increase more than 70% from 2020 to 2050, largely due to aging and population growth, according to forecasting model data published in The Lancet Rheumatology.
Genetics, long-term air pollutant exposure combine to increase lupus risk
Long-term exposure to air pollutants, including particulate matter, increases the risk for developing systemic lupus erythematosus, according to data published in Arthritis & Rheumatology.
Experts suggest COVID-19 prevention drug for immunocompromised patients
In new guidance, the Infectious Diseases Society of America suggested that immunocompromised patients take the monoclonal antibody pemivibart as pre-exposure prophylaxis to prevent severe COVID-19.
Tocilizumab taper increases time to relapse vs. abrupt withdrawal in giant cell arteritis
Tapering tocilizumab leads to a longer relapse-free period in patients with giant cell arteritis, compared with abrupt discontinuation, according to data published in Seminars in Arthritis and Rheumatism.
Olokizumab plus methotrexate safe, efficacious through 106 weeks in rheumatoid arthritis
Olokizumab combined with methotrexate for the treatment of rheumatoid arthritis maintains its safety and efficacy profile through 106 weeks, according to data published in Annals of the Rheumatic Diseases.
Biosimilars, originators discontinued at similar rates for inefficacy, adverse events
Subcutaneous TNF inhibitors and their biosimilars are discontinued due to inefficacy and adverse events at similar rates in patients with rheumatic diseases, according to data from Spain published in The Journal of Rheumatology.
‘Be the change agent’: Evidence-based practice can be achieved with 5 key steps
ORLANDO, Fla. — Evidence-based medical practices can be fostered through a five-step process that begins with asking the right questions, according to a presenter at the 2024 Rheumatology Nurses Society annual conference.
‘A large overlap’: Autoimmune encephalitis can look like, coexist with rheumatic disease
ORLANDO, Fla. — Although rheumatic diseases must be considered in a differential diagnosis of autoimmune encephalitis, some patients can have both, according to a presenter at the 2024 Rheumatology Nurses Society annual conference.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read